MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202647102529 A) filed by Silence Therapeutics Gmbh on August 25, 2026, for Nucleic Acids For Inhibiting Expression Of Gpr146 In A Cell.
Inventors include Morrison, Eliot; Dames, Sibylle; Czajkowski, Maciej; and Johannssen, Timo.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: The invention relates to double-stranded nucleic acid molecules that interfere with or inhibit G Protein-Coupled Receptor 146 (GPR146) gene expression. It further relates to therapeutic uses of such inhibition such as for the treatment of GPR146-mediated diseases, disorders or syndromes, such as hyperlipidaemia, hyperchole...